RecruitingNCT05677880

Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study

Studying OBSOLETE: Genetic cerebrovascular dementia

Last synced from ClinicalTrials.gov May 6, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University of Wisconsin, Madison
Principal Investigator: Jane S Paulsen, PhD
University of Wisconsin, Madison
Intervention: Study Procedures(other)
Enrollment: 660 enrolled
Eligibility: 18 years · All sexes
Timeline: 2022 – 2027

Study locations (12)

University of California, Los Angeles, California, United States
University of California, San Francisco, California, United States
University of Colorado, Denver, Colorado, United States
Georgia State University Research Foundation, Atlanta, Georgia, United States
Loyola University, Chicago, Illinois, United States
Columbia University, New York, New York, United States
Oregon Health & Science University, Portland, Oregon, United States
Brown University, Providence, Rhode Island, United States
University of Texas Health Science Center, Houston, Texas, United States
University of Texas, San Antonio, Texas, United States
University of Utah, Salt Lake City, Utah, United States
University of Washington, Seattle, Washington, United States

Collaborators

National Institute on Aging (NIA)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05677880 on ClinicalTrials.gov

Other trials for OBSOLETE: Genetic cerebrovascular dementia

Additional recruiting or active studies for the same condition.

See all trials for OBSOLETE: Genetic cerebrovascular dementia →

← Back to all trials